Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

773 Press Releases
DateTitleCompany
01 Apr 16 Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab Pfizer Inc.,
Published by
Business Wire
31 Mar 16 Pfizer Inc. (NYSE: PFE) today issued the following statement: Pfizer Inc.,
Published by
Business Wire
29 Mar 16 Pfizer Joins The Human Vaccines Project To Help Decode The Immune System Pfizer ,
Published by
PharmiWeb.com
29 Mar 16 Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts Pfizer ,
Published by
PharmiWeb.com
25 Mar 16 Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tofacitinib Citrate) for the Treatment of Moderate to Severe Rheumatoid Arthritis Pfizer ,
Published by
PharmiWeb.com
22 Mar 16 Pfizer Joins The Human Vaccines Project To Help Decode The Immune System Pfizer Inc.,
Published by
Business Wire
16 Mar 16 Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO Pfizer Inc.,
Published by
Business Wire
15 Mar 16 Pfizer Celebrates a Year of Achievements in 2015 Annual Review Pfizer Inc.,
Published by
Business Wire
08 Mar 16 Pfizer Announces Publication of Study Results of BeneFIX® Coagulation Factor IX (Recombinant) Once-Weekly Prophylaxis for Hemophilia B Pfizer Inc.,
Published by
Business Wire
26 Feb 16 Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis Pfizer ,
Published by
PharmiWeb.com
24 Feb 16 Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
16 Feb 16 WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX Pfizer,
Published by
Business Wire
10 Feb 16 Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications Pfizer Inc.,
Published by
Business Wire
04 Feb 16 PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE PFIZER ,
Published by
PharmiWeb.com
24 Jan 16 PFIZER CANADA CONGRATULATES THE ONTARIO GOVERNMENT FOR IMMUNIZATION 2020 STRATEGY PFIZER CANADA ,
Published by
PharmiWeb.com
15 Jan 16 Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations Pfizer ,
Published by
PharmiWeb.com
14 Jan 16 Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma Pfizer Inc.,
Published by
Business Wire
09 Jan 16 Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions Pfizer ,
Published by
PharmiWeb.com
08 Jan 16 Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions Pfizer Inc.,
Published by
Business Wire
10 Dec 15 New Phase III Study of Nintedanib in People with Systemic Sclerosis and Lung Fibrosis Launched Pfizer ,
Published by
PharmiWeb.com
05 Jan 16 Pfizer Invites Public to Listen to Webcast of Pfizer and Allergan Discussion at 34th Annual J.P. Morgan Healthcare Conference Pfizer Inc.,
Published by
Business Wire
21 Dec 15 Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder Pfizer Inc.,
Published by
Business Wire
22 Dec 15 Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
08 Jan 16 Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations Pfizer Inc.,
Published by
Business Wire
14 Dec 15 Pfizer Declares First-Quarter 2016 Dividend Pfizer Inc.,
Published by
Business Wire
14 Dec 15 Pfizer Declares First-Quarter 2016 Dividend Pfizer ,
Published by
PharmiWeb.com
14 Dec 15 Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Pfizer ,
Published by
PharmiWeb.com
04 Jan 16 Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer Pfizer Inc.,
Published by
Business Wire
11 Dec 15 Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer Pfizer ,
Published by
PharmiWeb.com
11 Dec 15 AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with Eliquis (apixaban) or Conventional Therapy Pfizer ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.